AAI
REGN icon

American Assets Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

American Assets Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$648K Buy
7,000
+5,200
+289% +$3.98M 0.22% 26
2025
Q4 		$1.39M Hold
1,800
– – 0.44% 7
2025
Q3 		$1.01M Hold
1,800
– – 0.32% 8
2025
Q2 		$883K Hold
1,800
– – 0.31% 12
2025
Q1 		$1.14M Buy
1,800
+1,200
+200% +$825K 0.4% 6
2024
Q4 		$427K Buy
+600
New +$504K 0.13% 14

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

American Assets Inc's REGN Position: Q1 2026 in Review

American Assets Inc increased its Regeneron Pharmaceuticals (REGN) stake by 289% in Q1 2026, buying an estimated $3.98M and bringing the position to 7,000 shares worth $648K. The position accounts for 0.22% of the portfolio, ranked #26.

American Assets Inc first reported a position in REGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.39M in Q4 2025. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • American Assets Inc held 7,000 shares of Regeneron Pharmaceuticals worth $648K as of Q1 2026.
  • American Assets Inc bought 5,200 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $3.98M.
  • Regeneron Pharmaceuticals made up 0.22% of American Assets Inc's portfolio in Q1 2026, its #26 holding.
  • American Assets Inc first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • American Assets Inc's Regeneron Pharmaceuticals position peaked at $1.39M in Q4 2025.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on American Assets Inc's 13F filing for Q1 2026, filed 11 May 2026.